Archive for the ‘Eisai’ tag

Aloxi

without comments

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Aloxi web site

without comments

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

AcipHex DTC print ad

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Acid reflux disease.
Burning. Bad taste in your throat. Belching.

Try AcipHex free for 2 weeks!
1-800-203-8672
TryAciphex.com/72

Brand name: AcipHex
Generic name/category: Rabeprazole, Prodrugs, Proton pump inhibitors, Benzimidazoles, Sulfoxides
Company: Eisai and PriCara
Country/Market: USA, North America
Indication(s)/use: Acid reflux disease
Target: Consumers (DTC) / Healthcare Professionals (HCP) / Trade
Tagline: Acid reflux disease. It’s got many faces.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Ladies’ Home Journal – October 2009

To see all of this brand’s ads on AdPharm, click here

Aricept Names TV commercial

without comments


Man lands at the airport, and forgets his grand-daughter's name.

Donepezil (also misspelled donezepil), marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine. Its binding to the acetylcholinesterase can be seen at Proteopedia 1eve. It has an oral bioavailability of 100% and easily crosses the blood-brain barrier. Because it has a half life of about 70 hours, it can be taken once a day. Initial dose is 5 mg per day, which can be increased to 10 mg per day after an adjustment period of at least 4 weeks.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: Aricept
Generic name/category: Donepezil, Anticholinesterases Antidementia agents
Company: Pfizer and Eisai
Country/Market: USA, North America
Indication(s)/use: Alzheimer's disease (AD)
Target: Consumers (DTC)
Tagline: Don't wait.
Medium: TV commercial
Size/duration: 60 seconds
Publication/Aired: 2009

To see all of the ads from this campaign, click here
To see all of this brand's ads on AdPharm, click here
0 views
Aug 27, 2009

Visit AdPharm.net for more pharmaceutical ads

Aricept Bowling Alley TV commercial

with 2 comments


Couple at the bowling alley.

Donepezil (also misspelled donezepil), marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer’s disease where it is used to increase cortical acetylcholine. Its binding to the acetylcholinesterase can be seen at Proteopedia 1eve. It has an oral bioavailability of 100% and easily crosses the blood-brain barrier. Because it has a half life of about 70 hours, it can be taken once a day. Initial dose is 5 mg per day, which can be increased to 10 mg per day after an adjustment period of at least 4 weeks.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: Aricept
Generic name/category: Donepezil, Anticholinesterases Antidementia agents
Company: Pfizer and Eisai
Country/Market: USA, North America
Indication(s)/use: Alzheimer’s disease (AD)
Target: Consumers (DTC)
Tagline: Don’t wait.
Medium: TV commercial
Size/duration: 60 seconds
Publication/Aired: 2009

To see all of the ads from this campaign, click here
To see all of this brand’s ads on AdPharm, click here
0 views
Aug 27, 2009

Read more here:
Aricept Bowling Alley TV commercial

Aricept’s new DTC campaign

without comments

TV commercials – Couple at bowling alley and couple at the airport

Print ad

Click on images to play the TV ads and to view a
full-size version of the print ad on AdPharm.

Brand name: Aricept
Generic name/category: Donepezil, Anticholinesterases Antidementia agents
Company: Pfizer and Eisai
Country/Market: USA, North America
Indication(s)/use: Alzheimer’s disease (AD)
Target: Consumers (DTC)
Tagline: Don’t wait.
Medium: single-page print ad and 60-second commercials
Publication/Aired: 2009

To see all of this brand’s ads on AdPharm, click here

Pharmacy care awards print ad

without comments

Recognizing pharmacists who support people with Alzheimer’s

For more information and to read about the most recent winner, visit http://www.carepharmacyaward.com

________________________________________________________________________

Brand name: Care Pharmacy Award
Generic name/category: Trade Awards
Company: Eisai and Alzheimer’s Association
Country/Market: USA, North America
Indication(s)/use: Industry recognition
Target: Healthcare Professionals (HCP) / Trade
Publication: Drug Topics June 2009